Literature DB >> 25778398

The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin.

Yuan Liu1, Travis Lear1, Olivia Iannone1, Sruti Shiva2, Catherine Corey2, Shristi Rajbhandari1, Jacob Jerome1, Bill B Chen3, Rama K Mallampalli4.   

Abstract

Fbxl7, a component of the Skp1·Cul1·F-box protein type ubiquitin E3 ligase, regulates mitotic cell cycle progression. Here we demonstrate that overexpression of Fbxl7 in lung epithelia decreases the protein abundance of survivin, a member of the inhibitor of apoptosis family. Fbxl7 mediates polyubiquitylation and proteasomal degradation of survivin by interacting with Glu-126 within its carboxyl-terminal α helix. Furthermore, both Lys-90 and Lys-91 within survivin serve as ubiquitin acceptor sites. Ectopically expressed Fbxl7 impairs mitochondrial function, whereas depletion of Fbxl7 protects mitochondria from actions of carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of oxidative phosphorylation. Compared with wild-type survivin, cellular expression of a survivin mutant protein deficient in its ability to interact with Fbxl7 (E126A) and a ubiquitylation-resistant double point mutant (KK90RR/KK91RR) rescued mitochondria to a larger extent from damage induced by overexpression of Fbxl7. Therefore, these data suggest that the Skp1·Cul1·F-box protein complex subunit Fbxl7 modulates mitochondrial function by controlling the cellular abundance of survivin. The results raise opportunities for F-box protein targeting to preserve mitochondrial function.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Cell Biology; E3 Ubiquitin Ligase; Lung Injury; Mitochondria; Oxygen; Protein Degradation

Mesh:

Substances:

Year:  2015        PMID: 25778398      PMCID: PMC4424325          DOI: 10.1074/jbc.M114.629931

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

Review 2.  The SCF ubiquitin ligase: insights into a molecular machine.

Authors:  Timothy Cardozo; Michele Pagano
Journal:  Nat Rev Mol Cell Biol       Date:  2004-09       Impact factor: 94.444

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 4.  Death receptors: signaling and modulation.

Authors:  A Ashkenazi; V M Dixit
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

5.  CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.

Authors:  Zhijun Li; Xin-Hai Pei; Jun Yan; Feng Yan; Kathryn M Cappell; Angelique W Whitehurst; Yue Xiong
Journal:  Mol Cell       Date:  2014-05-01       Impact factor: 17.970

6.  Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors.

Authors:  Jeffrey R Infante; E Claire Dees; Anthony J Olszanski; Shyeilla V Dhuria; Suman Sen; Scott Cameron; Roger B Cohen
Journal:  J Clin Oncol       Date:  2014-08-11       Impact factor: 44.544

7.  Emerging therapies targeting the ubiquitin proteasome system in cancer.

Authors:  Nathaniel M Weathington; Rama K Mallampalli
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

8.  XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer.

Authors:  Carolyn Cao; Yi Mu; Dennis E Hallahan; Bo Lu
Journal:  Oncogene       Date:  2004-09-16       Impact factor: 9.867

Review 9.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

10.  Control of apoptosis and mitotic spindle checkpoint by survivin.

Authors:  F Li; G Ambrosini; E Y Chu; J Plescia; S Tognin; P C Marchisio; D C Altieri
Journal:  Nature       Date:  1998-12-10       Impact factor: 49.962

View more
  29 in total

1.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

Review 2.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

3.  Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.

Authors:  Jun Li; Siyang Ren; Yongjian Liu; Zhigang Lian; Bin Dong; Yiqun Yao; Yinghui Xu
Journal:  J Neurooncol       Date:  2016-12-20       Impact factor: 4.130

Review 4.  F-box proteins involved in cancer-associated drug resistance.

Authors:  Jian Gong; Yuqian Zhou; Deliang Liu; Jirong Huo
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

Review 5.  Small molecule therapeutics targeting F-box proteins in cancer.

Authors:  Yuan Liu; Rama K Mallampalli
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

6.  The RNFT2/IL-3Rα axis regulates IL-3 signaling and innate immunity.

Authors:  Yao Tong; Travis B Lear; John Evankovich; Yanwen Chen; James D Londino; Michael M Myerburg; Yingze Zhang; Iulia D Popescu; John F McDyer; Bryan J McVerry; Karina C Lockwood; Michael J Jurczak; Yuan Liu; Bill B Chen
Journal:  JCI Insight       Date:  2020-02-13

7.  Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells.

Authors:  Qiyin Zhou; Hua Li; Yuanyuan Li; Mingjia Tan; Shaohua Fan; Cong Cao; Feilong Meng; Ling Zhu; Lili Zhao; Min-Xin Guan; Hongchuan Jin; Yi Sun
Journal:  JCI Insight       Date:  2019-02-21

8.  Aurora kinase A regulates Survivin stability through targeting FBXL7 in gastric cancer drug resistance and prognosis.

Authors:  M Kamran; Z-J Long; D Xu; S-S Lv; B Liu; C-L Wang; J Xu; E W-F Lam; Q Liu
Journal:  Oncogenesis       Date:  2017-02-20       Impact factor: 7.485

9.  Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation.

Authors:  Liang Tang; Meng Ji; Xing Liang; Danlei Chen; Anan Liu; Guang Yang; Ligang Shi; Zhiping Fu; Chenghao Shao
Journal:  Front Genet       Date:  2021-06-24       Impact factor: 4.599

10.  Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.

Authors:  Ming Li; Feng Gao; Xinfang Yu; Qing Zhao; Li Zhou; Wenbin Liu; Wei Li
Journal:  J Exp Clin Cancer Res       Date:  2020-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.